• Bristol Myers Squibb-backed Clade nabs a meaty $87M series A for cell therapy 2.0

    1 month ago - By Fierce Biotech

    Bristol Myers Squibb-backed Clade nabs a meaty $87M series A for cell therapy 2.0 badams
    Wed, 11/03/2021 - 05:36
    Read more ...

     

  • Pfizer tears up gene therapy timelines, revealing a series of phase 3 delays that end vision of a banner 2022

    1 month ago - By Fierce Biotech

    Pfizer tears up gene therapy timelines, revealing a series of phase 3 delays that end vision of a banner 2022 ntaylor
    Wed, 11/03/2021 - 07:23
    Read more ...